1. Home
  2. SFHG vs LSTA Comparison

SFHG vs LSTA Comparison

Compare SFHG & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$0.71

Market Cap

16.2M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$4.76

Market Cap

16.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFHG
LSTA
Founded
1993
1980
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Publishing
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
16.4M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
SFHG
LSTA
Price
$0.71
$4.76
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
81.4K
320.0K
Earning Date
10-30-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,577,200.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.56
N/A
52 Week Low
$0.32
$1.81
52 Week High
$1.29
$4.17

Technical Indicators

Market Signals
Indicator
SFHG
LSTA
Relative Strength Index (RSI) 41.94 90.18
Support Level $0.65 $2.05
Resistance Level $0.78 $4.17
Average True Range (ATR) 0.06 0.16
MACD -0.02 0.28
Stochastic Oscillator 25.32 93.98

Price Performance

Historical Comparison
SFHG
LSTA

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: